What I actually wrote was:
"
Early use of Zometa+CelebrexThe hazard ratio found for all metastatic men was:
STAMPEDE: 0.78
The no-brainer here is Zometa+Celebrex. As long as the patient doesn't have contraindications like heart disease or bad teeth, it is cheap, non-toxic, and reduced risk of death by 22% at the 43 month follow-up. Zometa is usually given along with ADT anyway, so it is hard to argue against including this combination along with Zytiga or docetaxel."
So if you're taking Zometa or Xgeva anyway, and you don't have heart problems, why would you NOT add Celebrex to it? The benefit was a survival gain of 22%. It only applies to men with bone mets.
/pcnrv.blogspot.com/2017/06/newly-diagnosed-metastatic-m1-but-still.html